Skip to main content
. 2012 Feb 15;2012(2):CD009665. doi: 10.1002/14651858.CD009665
Summary of results A: Pain‐free and headache relief in placebo controlled studies
  Studies Attacks
treated
Treatment
(%)
Placebo
(%)
Relative risk
(95% CI)
NNT
(95% CI)
Pain‐free at 2 hours            
Sumatriptan 4 mg 2 664 49 9 4.8 (3.2 to 7.2) 2.5 (2.2 to 3.0)
Sumatriptan 6 mg 13 2522 59 15 3.9 (3.3 to 4.5) 2.3 (2.1 to 2.4)
Sumatriptan 6 mg (+ 6 mg) 3 388 50 11 4.6 (2.9 to 7.4) 2.6 (2.1 to 3.2)
Pain‐free at 1 hour            
Sumatriptan 4 mg 2 664 33 6 4.7 (2.8 to 7.7) 3.8 (3.2 to 4.8)
Sumatriptan 6 mg 16 3592 41 7 5.6 (4.6 to 6.8) 2.9 (2.7 to 3.2)
Sumatriptan 8 mg 2 308 46 6 7.1 (3.8 to 13) 2.5 (2.0 to 3.2)
Headache relief at 1 hour            
Sumatriptan 4 mg 2 664 66 25 2.6 (2.0 to 3.2) 2.5 (2.1 to 3.0)
Sumatriptan 6 mg 24 5177 71 26 2.7 (2.5 to 2.9) 2.2 (2.1 to 2.4)
Sumatriptan 8 mg 3 361 80 23 3.6 (2.7 to 4.7) 1.7 (1.5 to 2.0)
Headache relief at 2 hours            
Sumatriptan 4 mg 2 664 70 22 3.1 (2.4 to 4.0) 2.1 (1.8 to 2.5)
Sumatriptan 6 mg 14 2738 79 31 2.5 (2.3 to 2.7) 2.1 (2.0 to 2.2)
Sumatriptan 6 mg (+6 mg) 6 1728 79 32 2.4 (2.1 to 2.7) 2.1 (1.9 to 2.3)
Sustained pain‐free during the 24 hours postdose            
Sumatriptan 6 mg 5 1336 31 15 2.2 (1.8 to 2.8) 6.1 (4.8 to 8.2)